ARTICLE SUMMARY:
In 2015, five major clinical trials were published demonstrating the benefits of endovascular mechanical thrombectomy devices for the treatment of acute ischemic stroke, ushering in a new era in stroke treatment. Now companies are working to expand approved indications and build appropriate systems of stroke care to ensure that their devices can be used to treat as many stroke patients as possible.
Over the past 25 years, the market for stroke devices has been based almost entirely on the prevention of hemorrhagic stroke, or the treatment of brain aneurysms before they rupture and cause bleeding in the brain.
